Should sponsors and DSMBs share interim results across trials?

Seema K Shah, Liza Dawson, Dennis O Dixon, Reidar K Lie
Author Information

Abstract

No abstract text available.

References

  1. J Med Ethics. 2008 Mar;34(3):198-201 [PMID: 18316463]
  2. Control Clin Trials. 1989 Dec;10(4 Suppl):209S-221S [PMID: 2605969]
  3. Ann Rheum Dis. 2008 Jul;67(7):1041-3 [PMID: 18180280]
  4. Arch Ophthalmol. 1993 Nov;111(11):1460-1; author reply 1463-5 [PMID: 8240093]
  5. PLoS Med. 2009 Jun 9;6(6):e1000071 [PMID: 19513106]
  6. BMJ. 2001 Aug 25;323(7310):441-2 [PMID: 11520848]
  7. Am Heart J. 2001 Apr;141(4):536-41 [PMID: 11275916]
  8. Clin Trials. 2004 Feb;1(1):60-79 [PMID: 16281463]
  9. Control Clin Trials. 2003 Feb;24(1):85-91 [PMID: 12559646]
  10. Arch Ophthalmol. 1993 Nov;111(11):1460; author reply 1463-5 [PMID: 8240092]
  11. Control Clin Trials. 2000 Feb;21(1):1-6; discussion 54-5 [PMID: 10659999]
  12. Clin Trials. 2008;5(2):157-67 [PMID: 18375654]
  13. IRB. 2000 Jan;22(1):7-11 [PMID: 12546010]
  14. Stat Med. 2002 Oct 15;21(19):2843-51 [PMID: 12325100]
  15. Control Clin Trials. 1999 Jun;20(3):229-41 [PMID: 10357496]

Grants

  1. Z99 CL999999/Intramural NIH HHS

MeSH Term

Anti-HIV Agents
Clinical Trials Data Monitoring Committees
Clinical Trials as Topic
Confidentiality
Female
HIV Infections
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical
Interinstitutional Relations
Nevirapine
Pregnancy
Zidovudine

Chemicals

Anti-HIV Agents
Zidovudine
Nevirapine